MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1210/jc.2014-2120

Медицинская библиотека · The Journal of clinical endocrinology and metabolism · 2014

Ovarian cancer-related hypophosphatemic osteomalacia--a case report.

Lin Hung-An, Shih Shyang-Rong, Tseng Yu-Ting, Chen Chi-Hau, Chiu Wei-Yih, Hsu Chih-Yao, Tsai Keh-Sung

Клинический случайСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused primarily by benign mesenchymal tumors. It has been associated with malignancies in rare cases. High serum levels of fibroblast growth factor (FGF) 23 reported in a group of patients with ovarian cancer had normal serum phosphate levels. There had been no ovarian cancer-related hypophosphatemic osteomalacia in a search of the literature.

OBJECTIVE

We investigated a 57-year-old woman with progressive low back pain.

DESIGN AND INTERVENTION: Clinical, biochemical, and radiological assessments were performed. The patient's serum phosphate and FGF23 levels were evaluated at baseline and after treatment for ovarian cancer.

RESULTS

The patient presented with progressive low back pain and weight loss during the previous 6 months. Imaging studies revealed low bone mineral density and multiple suspicious spinal metastatic lesions. Laboratory examination showed hypophosphatemia, hyperphosphaturia, normocalcemia, an elevated serum alkaline phosphatase level, and an elevated serum FGF23 level. Because TIO was suspected, a tumor survey was performed, and ovarian carcinoma with multiple metastasis was detected. After surgery and chemotherapy treatments for ovarian cancer, the serum phosphate and FGF23 levels returned to normal, and the low back pain improved.

CONCLUSIONS

To our knowledge, this is the first case of ovarian cancer-related hypophosphatemic osteomalacia reported in the literature. TIO should be considered in patients with ovarian cancer presenting with weakness, bone pain, and fractures. Investigation of TIO is appropriate when these patients present hypophosphatemia.

Для цитирования: Lin Hung-An, Shih Shyang-Rong, Tseng Yu-Ting, Chen Chi-Hau, Chiu Wei-Yih, Hsu Chih-Yao, Tsai Keh-Sung. Ovarian cancer-related hypophosphatemic osteomalacia--a case report.. The Journal of clinical endocrinology and metabolism. 2014. DOI: 10.1210/jc.2014-2120.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.